Old Web
English
Sign In
Acemap
>
Paper
>
NIMG-30. ASSESSING TREATMENT RESPONSE OF GLIOBLASTOMA TO AN HDAC INHIBITOR, BELINOSTAT (PXD101)
NIMG-30. ASSESSING TREATMENT RESPONSE OF GLIOBLASTOMA TO AN HDAC INHIBITOR, BELINOSTAT (PXD101)
2017
Saumya Gurbani
Soma Sengupta
Alfredo Voloschin
Zhongxing Liang
Younghyoun Yoon
Jose Enrique Velazquez Vega
Chad A. Holder
Jeffrey J. Olson
Hui-Kuo Shu
Hyunsuk Shim
Keywords:
Pathology
Glioblastoma
HDAC inhibitor
Cancer research
Histone deacetylase
Radiation therapy
Belinostat
Medicine
Immunology
standard of care
treatment response
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]